BPC-157 is not approved by Health Canada for any therapeutic indication
In addition, both preclinical and clinical literature often underrepresent females, limiting insights into sex-specific immunometabolic and hormonal modulators of treatment response (Seyedinia et al., 2023
Warehouses BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide consisting of 15 amino acids, derived from a partial sequence of a protective protein found in human gastric juice
Vitamin C neutralizes these harmful molecules, protecting your skin from further damage while helping repair existing issues
Managing an Elevated Heart Rate During Treatment Management of elevated heart rate during retatrutide treatment includes dose review, medication review, ensuring adequate hydration, and if tachycardia persists specialist referral or discontinuation, always in agreement with the trial investigator